Hepatitis virus infections leverage EV-encapsulated HBV-DNA and miRNA signatures (e.g., miR-21, miR-212) to detect occult infections and stratify liver fibrosis stages, while HCV-specific EV markers (CD81, miR-122) predict treatment response. This evidence concerns the gene CD81 and Hepatic fibrosis.